Trial Details
UNKNOWNBasic Information
| Clinical ID | c1452 |
|---|---|
| Identifier | NCT05014555 |
| Trial Title | Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: COVID-19 Vaccine |
Participant Information
| Sponsor | GI Alliance |
|---|---|
| City | Jacksonville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-07-05 |
|---|---|
| Primary Completion Date | 2024-01 |
| Completion Date | 2024-01 |